Does REMICADE Cause Interstitial lung disease? 13 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Interstitial lung disease have been filed in association with REMICADE. This represents 0.4% of all adverse event reports for REMICADE.
13
Reports of Interstitial lung disease with REMICADE
0.4%
of all REMICADE reports
3
Deaths
11
Hospitalizations
How Dangerous Is Interstitial lung disease From REMICADE?
Of the 13 reports, 3 (23.1%) resulted in death, 11 (84.6%) required hospitalization, and 1 (7.7%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REMICADE. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does REMICADE Cause?
Infusion related reaction (313)
Crohn's disease (193)
Drug ineffective (157)
Dyspnoea (141)
Exposure during pregnancy (96)
Arthralgia (95)
Nausea (85)
Pain (84)
Vomiting (81)
Malaise (80)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which REMICADE Alternatives Have Lower Interstitial lung disease Risk?
REMICADE vs REMIFENTANIL
REMICADE vs REMIMAZOLAM
REMICADE vs REMODULIN
REMICADE vs REPAGLINIDE
REMICADE vs REPOTRECTINIB